Key Performance
More- Earnings Score: N/A
- Momentum Score: 57
- True Yield: N/A
- Financial Health Score: N/A
%20scale(1,1)}%2025%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.943161px,19.954806px)%20scale(1,1)}}%20%23ewMkZ6d8Hun3_ts%20{animation:%20ewMkZ6d8Hun3_ts__ts%204000ms%20linear%20infinite%20normal%20forwards}@keyframes%20ewMkZ6d8Hun3_ts__ts%20{%200%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}%2025%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%2050%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.7,0.7)}%2075%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(0.85,0.85)}%20100%25%20{transform:%20translate(24.9787px,20.012362px)%20scale(1,1)}}%20]]%3e%3c/style%3e%3cdefs%3e%3clinearGradient%20id='ewMkZ6d8Hun2-fill'%20x1='12.5'%20y1='23.5001'%20x2='-0.868518'%20y2='16.4047'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun2-fill-0'%20offset='0%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun2-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3clinearGradient%20id='ewMkZ6d8Hun3-fill'%20x1='31.5059'%20y1='27.1026'%20x2='10.2884'%20y2='14.9373'%20spreadMethod='pad'%20gradientUnits='userSpaceOnUse'%20gradientTransform='translate(0%200)'%3e%3cstop%20id='ewMkZ6d8Hun3-fill-0'%20offset='4.7%25'%20stop-color='%23FF2F00'/%3e%3cstop%20id='ewMkZ6d8Hun3-fill-1'%20offset='100%25'%20stop-color='%23FF9100'/%3e%3c/linearGradient%3e%3c/defs%3e%3cg%20id='ewMkZ6d8Hun2_ts'%20transform='translate(24.943161,19.954806)%20scale(1,1)'%3e%3cpath%20d='M14.8466,29.2814c0,0-14.408088-4.6983-12.05895-19.79995c0,0,1.50345,4.85085,4.13448,5.30845s-2.03592,4.6373,7.92447,14.4915Z'%20transform='translate(-24.943161,-19.954806)'%20fill='url(%23ewMkZ6d8Hun2-fill)'/%3e%3c/g%3e%3cg%20id='ewMkZ6d8Hun3_ts'%20transform='translate(24.9787,20.012362)%20scale(1,1)'%3e%3cpath%20d='M37.4922,21.9282l4.0719.244v-12.81353C31.0713,3.28748,17.7595,7.6502,17.7595,7.6502c.3445-4.51526-3.5707-5.52204-3.5707-5.52204c2.5371,1.52542.3132,6.22373.3132,6.22373C13.0299,0.084092,0,1.02986,0,1.02986C8.92672,4.35528,6.70287,7.98579,6.8908,16.6197c.18794,8.6034,8.3943,12.9966,8.3943,12.9966l-6.60895-.2441v13.2407c0,0,5.48135,2.3797,13.68765,3.1729v-22.3017h-4.4477c-1.0023,0-1.942-.8237-1.942-1.8v-5.7356c0-.9763.9397-1.8,1.942-1.8h4.4477v-1.3424h5.0115v1.3424h5.0115c1.0023,0,1.848.7932,1.848,1.8v5.7356c0,.9763-.8144,1.8-1.848,1.8h-5.0115v22.5153h.2819c11.1192-.0611,15.9428-7.3221,16.256-13.3017.4698-7.7492-6.421-10.7695-6.421-10.7695Z'%20transform='translate(-24.9787,-20.012361)'%20fill='url(%23ewMkZ6d8Hun3-fill)'/%3e%3c/g%3e%3c/svg%3e)
Latest Research & News
DeepViewâ„¢ System Featured at 2025 US Burn Conferences
Spectral AI showcased its DeepView System at the Southern Region Burn Conference, demonstrating its AI technology for objective burn wound assessment. The company aims to improve patient outcomes and reduce healthcare costs through innovative medical diagnostics.
11/19/2025, 8:00 AM • GlobeNewswire
Spectral AI (MDAI) Q3 2025 Earnings Transcript
Spectral AI reported a net loss of $3.6 million in Q3 2025, reduced revenue guidance to $18.5 million, and anticipates a flat to slightly lower revenue year in 2026. The company continues to progress towards FDA clearance for its DeepView medical device and is expanding international market presence.
11/11/2025, 5:35 PM • The Motley Fool
Spectral AI Announces 2025 Third Quarter Financial Results
Spectral AI reported Q3 2025 financial results with $3.8 million in research and development revenue, a net loss of $3.6 million, and a strong cash position of $10.5 million. The company continues to progress towards FDA De Novo submission for its DeepView® System in wound care diagnostics.
11/11/2025, 4:00 PM • GlobeNewswire
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
Spectral AI will report its third quarter 2025 financial results on November 11, 2025, after market close, with a conference call to discuss the results.
10/28/2025, 4:00 PM • GlobeNewswire
Spectral AI Named to TIME’s List of World’s Top HealthTech Companies 2025
Spectral AI, a medical diagnostics AI company, was recognized on TIME's World's Top HealthTech Companies 2025 list for its innovative DeepView technology focused on wound care and burn treatment diagnostics.
09/19/2025, 8:00 AM • GlobeNewswire
DeepView® System highlighted at the European Burns Association Congress
Spectral AI showcased its DeepView multispectral imaging technology for burn wound assessment at the European Burns Association conference in Berlin, presenting multiple research studies demonstrating the system's potential in improving burn care diagnostics.
09/10/2025, 8:00 AM • GlobeNewswire
Spectral Ai Posts 32% Revenue Drop in Q2
Spectral Ai reported Q2 2025 financial results with a 32% revenue decline, completed FDA De Novo submission for DeepView System, and maintained fiscal year revenue guidance of $21.5 million, primarily from government research contracts.
08/13/2025, 4:19 PM • The Motley Fool
Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call
Spectral AI will report its Q2 2025 financial results on August 12, 2025, after market close, with a conference call to discuss the results.
07/30/2025, 8:00 AM • GlobeNewswire
AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
The White House is encouraging AI adoption in healthcare through regulatory sandboxes, with several tech and biotech companies advancing AI-powered healthcare solutions focused on diagnostics, drug development, and workflow optimization.
07/29/2025, 3:01 PM • Benzinga
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.